M
422.12
-1.75 (-0.41%)
| 前收盘价格 | 423.87 |
| 收盘价格 | 426.63 |
| 成交量 | 35,314 |
| 平均成交量 (3个月) | 357,500 |
| 市值 | 9,408,694,272 |
| 价格/销量 (P/S) | 19.18 |
| 股市价格/股市净资产 (P/B) | 14.40 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2025 |
| 营业毛利率 | -123.38% |
| 营业利益率 (TTM) | -57.79% |
| 稀释每股收益 (EPS TTM) | -17.83 |
| 总债务/股东权益 (D/E MRQ) | 16.85% |
| 流动比率 (MRQ) | 5.91 |
| 营业现金流 (OCF TTM) | -395.31 M |
| 杠杆自由现金流 (LFCF TTM) | -274.11 M |
| 资产报酬率 (ROA TTM) | -25.56% |
| 股东权益报酬率 (ROE TTM) | -50.16% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Madrigal Pharmaceuticals, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
1.6
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.63 |
|
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 7.73% |
| 机构持股比例 | 108.28% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Paulson & Co. Inc. | 30 Jun 2025 | 2,089,523 |
| Avoro Capital Advisors Llc | 30 Jun 2025 | 1,875,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 590.00 (Oppenheimer, 39.77%) | 购买 |
| 中 | 540.00 (27.93%) | |
| 低 | 485.00 (JMP Securities, 14.90%) | 购买 |
| 平均值 | 539.78 (27.87%) | |
| 总计 | 9 购买 | |
| 平均价格@调整类型 | 419.84 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Piper Sandler | 15 Oct 2025 | 540.00 (27.92%) | 购买 | 433.45 |
| Truist Securities | 15 Oct 2025 | 580.00 (37.40%) | 购买 | 433.45 |
| Oppenheimer | 10 Oct 2025 | 590.00 (39.77%) | 购买 | 429.60 |
| B. Riley Securities | 29 Sep 2025 | 560.00 (32.66%) | 购买 | 443.10 |
| Canaccord Genuity | 12 Sep 2025 | 526.00 (24.61%) | 购买 | 432.22 |
| 06 Aug 2025 | 428.00 (1.39%) | 购买 | 338.11 | |
| HC Wainwright & Co. | 04 Sep 2025 | 500.00 (18.45%) | 购买 | 431.21 |
| TD Cowen | 26 Aug 2025 | 554.00 (31.24%) | 购买 | 424.86 |
| JMP Securities | 20 Aug 2025 | 485.00 (14.90%) | 购买 | 391.66 |
| UBS | 12 Aug 2025 | 523.00 (23.90%) | 购买 | 359.00 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合